All
Aerospace, Defense & Security
Banking, Financial Services & Insurance
Chemicals, Materials & Polymers
Energy & Power
FMCG & Consumer Products
Healthcare & Life Sciences
Heavy Machinery & Equipment
Industrial Automation & Mobility
Information Technology & Electronics
Healthcare-Life-Sciences Market Reports
Comprehensive industry analysis, market size, and forecast for healthcare-life-sciences.
Showing 101 - 110 of 791 reports
Optic Nerve Atrophy Treatment Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: USD 1.8 billion Market Size 2034: USD 3.2 billion CAGR: 5.9% Market Definition: Optic nerve atrophy treatment encompasses pharmaceutical therapies, neuroprotective agents, and emerging gene therapies designed to prevent further degeneration and potentially restore visual function in patients with damaged …
Read More
Ringing Ears Treatment Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: $2.8 billion Market Size 2034: $4.9 billion CAGR: 5.8% Market Definition: Ringing ears treatment encompasses pharmaceutical drugs, medical devices, and therapeutic interventions designed to manage tinnitus symptoms and underlying auditory disorders. Products include prescription medications, hearing aids with tinnitus maskers, …
Read More
Artificial Lung Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: USD 2.8 billion Market Size 2034: USD 8.1 billion CAGR: 11.2% Market Definition: Artificial lungs encompass external membrane oxygenation devices and implantable lung replacement technologies designed to support or replace natural lung function in patients with severe respiratory failure. These …
Read More
High-Density Cell Banking Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: USD 3.2 billion Market Size 2034: USD 8.7 billion CAGR: 10.5% Market Definition: High-density cell banking involves the storage and management of concentrated cell cultures in specialized facilities using advanced cryopreservation and automated systems. These banks serve biopharmaceutical companies, research …
Read More
Helicobacter pylori Infections Treatment Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: $5.8 billion Market Size 2034: $9.2 billion CAGR: 4.7% Market Definition: Pharmaceutical therapies for treating Helicobacter pylori bacterial infections, including antibiotic combinations, proton pump inhibitors, and bismuth-based regimens targeting gastric ulcers and gastritis. Leading Companies: Takeda Pharmaceutical, AbbVie, Pfizer, Merck …
Read More
Encephalitis Vaccines Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: $1.8 billion Market Size 2034: $3.2 billion CAGR: 5.9% Market Definition: Vaccines designed to prevent viral and bacterial encephalitis infections, including Japanese encephalitis, tick-borne encephalitis, and other region-specific variants. These vaccines are administered primarily through pediatric immunization programs and travel …
Read More
Pharmaceutical Dextran Glucose Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: $1.2 billion Market Size 2034: $2.1 billion CAGR: 5.8% Market Definition: Pharmaceutical dextran glucose encompasses sterile, biocompatible polysaccharide solutions used primarily as plasma volume expanders, drug delivery carriers, and stabilising agents in pharmaceutical formulations. These glucose-derived polymers offer controlled molecular …
Read More
Pharmaceutical Intermediate Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: $59.2 billion Market Size 2034: $98.7 billion CAGR: 5.8% Market Definition: Pharmaceutical intermediates are chemical compounds used as building blocks in the synthesis of active pharmaceutical ingredients (APIs). These compounds undergo further chemical transformation before becoming the final drug substance …
Read More
Brucellosis Vaccine Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: $195.6 million Market Size 2034: $328.4 million CAGR: 5.3% Market Definition: Brucellosis vaccines are immunological preparations designed to prevent brucellosis, a zoonotic disease caused by Brucella bacteria affecting livestock and humans. These vaccines include live attenuated, inactivated, and recombinant formulations …
Read More
Pharmaceutical Elixir Market Size, Share & Forecast 2026–2034
Report Highlights Market Size 2024: $2.8 billion Market Size 2034: $4.7 billion CAGR: 5.3% Market Definition: Pharmaceutical elixirs are sweetened, flavored liquid formulations containing active pharmaceutical ingredients dissolved in a hydroalcoholic solution, designed for oral administration. These clear, homogeneous solutions provide enhanced patient compliance through …
Read More